Bio-Rad Laboratories (BIO) Total Current Liabilities (2009 - 2026)

Bio-Rad Laboratories (BIO) has reported Total Current Liabilities for 18 consecutive years, with $961.3 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Total Current Liabilities rose 75.13% year-over-year to $961.3 million in Q2 2026; TTM through Jun 2026 was $961.3 million, a 75.13% increase from a year earlier, with the FY2025 full-year figure at $517.0 million, up 10.52% from the prior year.
• Total Current Liabilities was $961.3 million for Q2 2026 at Bio-Rad Laboratories, up from $917.0 million in the prior quarter.
• Over five years, Total Current Liabilities peaked at $961.3 million in Q2 2026 and troughed at $466.2 million in Q1 2024.
• A 5-year average of $585.9 million and a median of $553.5 million in 2023 frame the typical range for Total Current Liabilities.
• Across the five-year window, Total Current Liabilities fell 20.94% in 2024 and soared 81.01% in 2026, its largest moves.
• Over 5 years, Total Current Liabilities stood at $568.7 million in 2022, then declined by 8.07% to $522.8 million in 2023, then dropped by 10.52% to $467.8 million in 2024, then increased by 10.52% to $517.0 million in 2025, then jumped by 85.94% to $961.3 million in 2026.
• The last three Total Current Liabilities figures came in at $961.3 million (Q2 2026), $917.0 million (Q1 2026), and $517.0 million (Q4 2025), per Business Quant data.